Rocket Lab USA is trading 8.3% down at $73.40 after investors focused on its wider-than-expected Q2 adjusted loss of $0.08 per share.
- Record revenue reached $234.1 million, with strong Q3 guidance and a record backlog.
- Continued cash burn and uncertainty surrounding the Neutron rocket’s maiden launch timeline weighed on sentiment.
- The broader market is nearly flat, making the decline appear primarily company-specific.